The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incorporation of intrapatient response heterogeneity using 18F-NaF PET/CT imaging improves outcome prediction models for metastatic prostate cancer patients.
 
Timothy G. Perk
Employment - AIQ Solutions
Stock and Other Ownership Interests - AIQ Solutions
Patents, Royalties, Other Intellectual Property - Apparatus for Monitoring Treatment Side Effects (patent pending) Healthy organ systems are monitored over time and used to identify adverse events in those organs.; ASSESSMENT OF DISEASE TREATMENT (patent pending) This system takes in various imaging metrics and can provide an estimate of how effective a treatment has been for a specific patient, i.e. is a patient going to have a short or a long benefit from the curr; Image Enhancement System for Bone Disease Evaluation A standardized skeleton template is used to normalize medical image data of the skeleton to eliminate variations in the medical image data related to physiological variations in a normal patient thereby; System and Method for Monitoring Multiple Lesions (patent pending) The system uses registration and optimization to accurately determine which lesions are the same between multiple imaging timepoints.
 
Stephen S.F. Yip
Employment - AIQ Solutions; Janssen Research & Development
Leadership - AIQ Solutions
Stock and Other Ownership Interests - AIQ Solutions; AIQ Solutions; Janssen Research & Development
 
Amy J. Weisman
Employment - AIQ Solutions
 
Sean S. Houshmandi
Patents, Royalties, Other Intellectual Property - ASSESSMENT OF DISEASE TREATMENT (patent pending) This system takes in various imaging metrics and can provide an estimate of how effective a treatment has been for a specific patient, i.e. is a patient going to have a short or a long benefit from the curr
 
Elisabeth I. Heath
Honoraria - Bayer; Sanofi; Seagen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Sanofi
Speakers' Bureau - Sanofi
Research Funding - Agensys (Inst); AIQ Solutions (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calibr (Inst); Caris Life Sciences (Inst); Celgene (Inst); Celldex (Inst); Champions Oncology (Inst); Corcept Therapeutics (Inst); Curemeta (Inst); Daiichi Sankyo Inc. (Inst); Dendreon (Inst); eFFECTOR Therapeutics (Inst); Eisai (Inst); Esanik (Inst); Five Prime Therapeutics (Inst); Fortis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Infinity Pharmaceuticals (Inst); Inovio Pharmaceuticals (Inst); Janssen Research & Development (Inst); Medivation (Inst); Merck (Inst); Merck Sharp & Dohme (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Modra Pharmaceuticals (Inst); Novartis (Inst); Oncolys BioPharma (Inst); Pellficure (Inst); Peloton Therapeutics (Inst); Pharmacyclics (Inst); Plexxikon (Inst); Seagen (Inst); Synta (Inst); Tokai Pharmaceuticals (Inst); Zenith Epigenetics (Inst); Zenith Epigenetics (Inst)
Other Relationship - Caris Centers of Excellence
 
Michael J. Morris
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Advanced Accelerator Applications; Athenex; Bayer; Curium Pharma; Endocyte; Exelixis; Johnson & Johnson; Lantheus Medical Imaging; NCCN; Novartis; ORIC Pharmaceuticals; Progenics
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Janssen (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Endocyte; Fujifilm
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
Research Funding - Bayer
 
Douglas G. McNeel
Leadership - Madison Vaccines, Inc.
Stock and Other Ownership Interests - Madison Vaccines, Inc.
Consulting or Advisory Role - Cellvax; Janssen; Madison Vaccines, Inc.; SapVax
Research Funding - Bristol-Myers Squibb (Inst); Harpoon therapeutics (Inst); Janssen (Inst); Madison Vaccines, Inc. (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patents that have been licensed by UW to Madison Vaccines, Inc
Travel, Accommodations, Expenses - Madison Vaccines, Inc.
 
Andrea B. Apolo
No Relationships to Disclose
 
Christos Kyriakopoulos
Consulting or Advisory Role - AVEO; EMD Serono; Exelixis; Janssen Oncology; Janssen Oncology; Sanofi
Research Funding - Sanofi
 
Glenn Liu
Employment - AIQ Solutions
Leadership - AIQ Solutions
Stock and Other Ownership Interests - AIQ Solutions
Consulting or Advisory Role - Janssen medical Affairs
Research Funding - Johnson & Johnson (Inst); Madison Vaccines, Inc.; Novartis (Inst); Pfizer; TRACON Pharma
Patents, Royalties, Other Intellectual Property - I have patent pending titled "System and method for evaluation of disease burden" which provides a novel method to identify and quantitate treatment response. (Inst)
 
Robert Jeraj
Stock and Other Ownership Interests - AIQ Solutions
Research Funding - AIQ Solutions (Inst)
Patents, Royalties, Other Intellectual Property - Several Wisconsin Alumni Research Foundation patents